Endoplasmic Reticulum Stress: At the Crossroads of Inflammation and Metabolism in Hepatocellular Carcinoma Development  Marion Maurel, Afshin Samali,

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development Hayato Nakagawa, Atsushi Umemura, Koji Taniguchi, Joan Font-Burgada,
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Charles Swanton, Julian Downward  Cancer Cell 
Obesity and Cancer: The Oil that Feeds the Flame
PNPLA3 gene in liver diseases
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
Volume 47, Issue 3, Pages (September 2017)
Figure 2 The unfolded protein response
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
Volume 47, Issue 1, Pages (July 2007)
A Novel ER Stress-Independent Function of the UPR in Angiogenesis
Lymphotoxins: New Targets for Hepatocellular Carcinoma
All roads lead to FoxO Cell Metabolism
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
Liver – master and servant of serum proteome
Volume 142, Issue 6, Pages (May 2012)
Figure 3 Unfolded protein response pathways and interventions
Endoplasmic reticulum stress in liver disease
Figure 1 ER stress and associated lines of defence
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
A Novel ER Stress-Independent Function of the UPR in Angiogenesis
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
A Radical Role for p38 MAPK in Tumor Initiation
Muscle Over Mind Cell Metabolism
Metastasis-Promoting Immunity: When T Cells Turn to the Dark Side
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
Volume 62, Issue 1, Pages (January 2015)
Insulin biosynthesis: The IREny of it all
ER Stress in Dendritic Cells Promotes Cancer
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Eukaryotic Transcription Activation: Right on Target
The Skinny on Fat Trm Cells
Volume 154, Issue 1, Pages (January 2018)
Autophagy: A Potential Link between Obesity and Insulin Resistance
Osteoarthritis and Cartilage
NRG4: An Endocrine Link between Brown Adipose Tissue and Liver
HIV Drug to Aid Melanoma Therapies?
Volume 69, Issue 4, Pages (October 2018)
Volume 140, Issue 6, Pages (March 2010)
Volume 14, Issue 2, Pages (August 2008)
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
A New FOXO Pathway Required for Leukemogenesis
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Banking on ATM as a new target in metabolic syndrome
NASH animal models: Are we there yet?
Sugarcoating ER Stress
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Volume 21, Issue 6, Pages (June 2012)
Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma
Mst Out and HCC In Cancer Cell
Role reversal: Brain insulin and liver STAT3
Volume 10, Issue 3, Pages (September 2006)
Sander Lefere, Frank Tacke  JHEP Reports 
All Roads Lead to the Ribosome
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
The TRIP from ULF to ARF Cancer Cell
Volume 24, Issue 1, Pages 7-8 (July 2016)
Of Mice and Men: Not ExAKTly the Same?
UPR and cross-talk between apoptosis and metabolism.
Connecting with an Old Partner in a New Way
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Angiotensin in the Kidney: A Key to Understanding Hypertension?
Estrogens and Obesity: Is It All in Our Heads?
Zuzana Tothova, D. Gary Gilliland  Cell Stem Cell 
Skp2, the FoxO1 hunter Cancer Cell
Presentation transcript:

Endoplasmic Reticulum Stress: At the Crossroads of Inflammation and Metabolism in Hepatocellular Carcinoma Development  Marion Maurel, Afshin Samali, Eric Chevet  Cancer Cell  Volume 26, Issue 3, Pages 301-303 (September 2014) DOI: 10.1016/j.ccr.2014.08.007 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 ER Stress in Steatohepatitis-Induced Hepatocarcinogenesis (A) Schematic timeline of HCC progression as reported by Nakagawa et al. (2014). MUP-uPA mice, although exhibiting ER stress in the liver, did not develop HCC, whereas signs of steatosis and weak fibrosis can be observed. On HFD, C57BL/6 mice developed steatosis, steatohepatitis, and HCC (in a TNFR1-dependent manner) over a period of 40 weeks. Finally, HFD applied to MUP-uPA mice led to a more penetrant HCC phenotype than in wild-type animals, thus demonstrating the synergistic impact of combined ER stress and HFD on HCC development. (B) Qualitative representation of the intensity of ER stress observed in the models studied by Nakagawa et al. (2014). MUP-uPA mice presented a strong basal ER stress, which dissipated over time with hepatocyte renewal. In contrast, HFD-induced ER stress increases with time. Finally, HFD in MUP-uPA mice led to prolonged and reinforced ER stress throughout the experimental pipeline, thus correlating ER stress intensity with HCC outcome. (C) Qualitative representation of the relevance of ER stress signaling components toward HCC development upon HFD. The IRE1 arm of the UPR appears to play a significant role in steatosis-induced HCC, because the phosphorylation of IRE1 and the activation of JNK are increased and 25% of RIDD targets impact lipid metabolism (although RIDD was not investigated by Nakagawa et al., 2014). The latter is also a direct target of TNF signaling through TNFR1 and thus represents a point of convergence of two of the signaling pathways involved in hepatocarcinogenesis. The activation of SREBP1 also represents an important factor activated upon ER stress that stimulates lipogenesis and enhances the steatotic/steatohepatitic phenotype. Interestingly, the phosphorylation of eIF2α is also observed and relevant, but it might also be due to the activation of the integrated stress response, a key player in metabolic syndrome. Finally, both CHOP and XBP1s appear dispensable for steatohepatitis-induced HCC development. The respective roles of ATF4 and ATF6 remain to be investigated (dotted bars). Cancer Cell 2014 26, 301-303DOI: (10.1016/j.ccr.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions